
Tamcrez 0.4mg Tablet MR
Marketer
Cryzer Formulation
Salt Composition
Tamsulosin (0.4mg)
Overview Tamcrez 0.4mg Tablet MR
Alfuzosin 0.4mg Modified-Release tablets are alpha-blockers indicated for benign prostatic hyperplasia (BPH). They alleviate urinary symptoms such as hesitancy, but don't shrink the prostate. Always follow your doctor's prescribed dosage and regimen. This medication can be taken with or without food, but consistently at the same time each day. Swallow the tablet whole; do not crush or chew. Discontinuing treatment prematurely may worsen symptoms; complete the prescribed course for optimal results. Common side effects include lightheadedness, backache, chest discomfort, altered ejaculation, and retrograde ejaculation. Report any persistent or bothersome side effects to your physician immediately. Lifestyle adjustments can aid symptom management. Void your bladder promptly when you feel the urge, but avoid straining. Limit evening and pre-sleep consumption of caffeine and alcohol. Before starting treatment, disclose all other medications and pre-existing conditions to your doctor. If cataract or glaucoma surgery is planned, inform your ophthalmologist about your alfuzosin use. Patients with liver impairment require close monitoring and regular check-ups under their physician's guidance.
Uses of Tamcrez 0.4mg Tablet MR
Managing benign prostatic enlargement
Major Benefits of Tamcrez 0.4mg Tablet MR:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Tamcrez 0.4mg Modified-Release Tablet can be consumed with or without food, however, consistent daily timing is recommended.
Common Side effects of Tamcrez 0.4mg Tablet MR:
- Chest pain
- Inflammation of the nose
- Dizziness
- Ejaculation disorder
- Headache
- Abdominal pain
- Back pain
- Nausea
- Infection
How to use Tamcrez 0.4mg Tablet MR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Tamcrez 0.4mg Modified-Release Tablet can be administered with or without food, though consistent timing is recommended.
How Tamcrez 0.4mg Tablet MR works:
Tamcrez 0.4mg Modified-Release tablets contain an alpha-adrenergic blocking agent. Its mechanism involves relaxing bladder neck and prostatic smooth muscle, facilitating more effortless urination. This improved bladder emptying lessens urinary frequency and urgency associated with benign prostatic hyperplasia (BPH).
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of Tamcrez 0.4mg Modified-Release Tablets and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Tamcrez 0.4mg Modified-Release tablets in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
The use of Tamcrez 0.4mg Tablet MR while breastfeeding is likely unsafe. Available human data indicates potential transfer to breast milk, posing a risk to the infant. This medication is contraindicated in women.
DrivingSAFE
Driving ability is typically unaffected by Tamcrez 0.4mg MR tablets.
KidneySAFE IF PRESCRIBED
Tamcrez 0.4mg modified-release tablets are considered safe for individuals with kidney impairment; no dosage alteration is typically necessary. Nevertheless, data regarding its use in patients with end-stage renal disease is scarce. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Tamcrez 0.4mg modified-release tablets cautiously. Dosage modification of Tamcrez 0.4mg modified-release tablets may be necessary. Physician consultation is advised.
What if you forget to take Tamcrez 0.4mg Tablet MR :
Should you forget a dose of your Tamcrez 0.4mg MR tablet, take it immediately if you remember. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Tamcrez 0.4mg Tablet MR
| Label | Value |
|---|---|
| Chemical Type | Sulfonamide-based compound |
| Developing Habits | No. |
| Type of Therapy | Urology |
